ARGOS THERAPEUTICS INC 4
4 · ARGOS THERAPEUTICS INC · Filed Jul 13, 2016
Insider Transaction Report
Form 4
Katz Richard D
VP & Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2016-07-11+300,000→ 300,000 totalExercise: $6.30Exp: 2026-07-10→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]This option was granted on July 11, 2016 and vests as to 25% of the shares underlying this option on July 11, 2017, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning July 11, 2017.